Golino, P., Ragni, M., Cimmino, G., & Forte, L. (2002). Role of tissue factor pathway inhibitor in the regulation of tissue factor-dependent blood coagulation. Cardiovascular Drug Reviews, 20(1), 67–80. https://doi.org/10.1111/j.1527-3466.2002.tb00083.x

Article  PubMed  Google Scholar 

Chand, H. S., Foster, D. C., & Kisiel, W. (2005). Structure, function and biology of tissue factor pathway inhibitor-2. Thrombosis and Haemostasis, 94(6), 1122–1130. https://doi.org/10.1160/TH05-07-0509

Article  PubMed  Google Scholar 

Bohn, H., & Winckler, W. (1977). Isolation and characterization of the placental protein pp5 (author’s transl). Archiv für Gynäkologie, 223(3), 179–186. https://doi.org/10.1007/BF00667387

Article  PubMed  Google Scholar 

Seppälä, M., Wahlström, T., & Bohn, H. (1979). Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and trophoblastic disease: Absence of PP5 expression in the malignant trophoblast. International Journal of Cancer, 24(1), 6–10. https://doi.org/10.1002/ijc.2910240103

Article  PubMed  Google Scholar 

Miyagi, Y., Koshikawa, N., Yasumitsu, H., Miyagi, E., Hirahara, F., Aoki, I., et al. (1994). cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: Identification as placental protein 5 and tissue factor pathway inhibitor-2. Journal of Biochemistry, 116(5), 939–942. https://doi.org/10.1093/oxfordjournals.jbchem.a124648

Article  PubMed  Google Scholar 

Sprecher, C. A., Kisiel, W., Mathewes, S., & Foster, D. C. (1994). Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proc Natl Acad Sci U S A, 91(8), 3353–3357. https://doi.org/10.1073/pnas.91.8.3353

Article  PubMed  PubMed Central  Google Scholar 

Miyagi, Y., Yasumitsu, H., Eki, T., Miyata, S., Kkawa, N., Hirahara, F., et al. (1996). Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis. Genomics, 35(1), 267–268. https://doi.org/10.1006/geno.1996.0353

Article  PubMed  Google Scholar 

Rao, C. N., Reddy, P., Liu, Y., O’Toole, E., Reeder, D., Foster, D. C., et al. (1996). Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: CDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2. Archives of Biochemistry and Biophysics, 335(1), 82–92. https://doi.org/10.1006/abbi.1996.0484

Article  PubMed  Google Scholar 

Broze, G. J., Girard, T. J., & Novotny, W. F. (1990). Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry, 29(33), 7539–7546. https://doi.org/10.1021/bi00485a001

Article  PubMed  Google Scholar 

Petersen, L. C., Sprecher, C. A., Foster, D. C., Blumberg, H., Hamamoto, T., & Kisiel, W. (1996). Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry, 35(1), 266–272. https://doi.org/10.1021/bi951501d

Article  PubMed  Google Scholar 

Kamei, S., Petersen, L. C., Sprecher, C. A., Foster, D. C., & Kisiel, W. (1999). Inhibitory properties of human recombinant Arg24–>Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2). Thrombosis Research, 94(3), 147–152. https://doi.org/10.1016/s0049-3848(98)00205-9

Article  PubMed  Google Scholar 

Chand, H. S., Schmidt, A. E., Bajaj, S. P., & Kisiel, W. (2004). Structure-function analysis of the reactive site in the first Kunitz-type domain of human tissue factor pathway inhibitor-2. Journal of Biological Chemistry, 279(17), 17500–17507. https://doi.org/10.1074/jbc.M400802200

Article  PubMed  Google Scholar 

Vadivel, K., Ponnuraj, S. M., Kumar, Y., Zaiss, A. K., Bunce, M. W., Camire, R. M., et al. (2014). Platelets contain tissue factor pathway inhibitor-2 derived from megakaryocytes and inhibits fibrinolysis. Journal of Biological Chemistry, 289(45), 31647–31661. https://doi.org/10.1074/jbc.M114.569665

Article  PubMed  PubMed Central  Google Scholar 

Kobayashi, H., & Imanaka, S. (2021). Toward an understanding of tissue factor pathway inhibitor-2 as a novel serodiagnostic marker for clear cell carcinoma of the ovary. The Journal of Obstetrics and Gynaecology Research, 47(9), 2978–2989. https://doi.org/10.1111/jog.14916

Article  PubMed  Google Scholar 

Ali, M. N., Kasetty, G., Elvén, M., Alyafei, S., Jovic, S., Egesten, A., et al. (2018). TFPI-2 Protects Against Gram-Negative Bacterial Infection. Frontiers in Immunology, 9, 2072. https://doi.org/10.3389/fimmu.2018.02072

Article  PubMed  PubMed Central  Google Scholar 

Xu, C., Deng, F., Mao, Z., Zhang, J., Wang, H., Wang, J., et al. (2012). The interaction of the second Kunitz-type domain (KD2) of TFPI-2 with a novel interaction partner, prosaposin, mediates the inhibition of the invasion and migration of human fibrosarcoma cells. The Biochemical Journal, 441(2), 665–674. https://doi.org/10.1042/BJ20110533

Article  PubMed  Google Scholar 

Xu, Y., Qin, X., Zhou, J., Tu, Z., Bi, X., Li, W., et al. (2011). Tissue factor pathway inhibitor-2 inhibits the growth and invasion of hepatocellular carcinoma cells and is inactivated in human hepatocellular carcinoma. Oncology Letters, 2(5), 779–783. https://doi.org/10.3892/ol.2011.340

Article  PubMed  PubMed Central  Google Scholar 

Vaitkienė, P., Skiriutė, D., Skauminas, K., & Tamašauskas, A. (2012). Associations between TFPI-2 methylation and poor prognosis in glioblastomas. Medicina (Kaunas, Lithuania), 48(7), 345–349.

PubMed  Google Scholar 

Lavergne, M., Jourdan, M. L., Blechet, C., Guyetant, S., Pape, A. L., Heuze-Vourc’h, N., et al. (2013). Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer. FEBS Open Bio, 3, 291–301. https://doi.org/10.1016/j.fob.2013.06.004

Article  PubMed  PubMed Central  Google Scholar 

Herman, M. P., Sukhova, G. K., Kisiel, W., Foster, D., Kehry, M. R., Libby, P., et al. (2001). Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. The Journal of Clinical Investigation, 107(9), 1117–1126. https://doi.org/10.1172/JCI10403

Article  PubMed  PubMed Central  Google Scholar 

Peerschke, E. I., Petrovan, R. J., Ghebrehiwet, B., & Ruf, W. (2004). Tissue factor pathway inhibitor-2 (TFPI-2) recognizes the complement and kininogen binding protein gC1qR/p33 (gC1qR): Implications for vascular inflammation. Thrombosis and Haemostasis, 92(4), 811–819. https://doi.org/10.1160/TH04-03-0188

Article  PubMed  Google Scholar 

van Hinsbergh, V. W., Engelse, M. A., & Quax, P. H. (2006). Pericellular proteases in angiogenesis and vasculogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 26(4), 716–728. https://doi.org/10.1161/01.ATV.0000209518.58252.17

Article  PubMed  Google Scholar 

Shinoda, E., Yui, Y., Hattori, R., Tanaka, M., Inoue, R., Aoyama, T., et al. (1999). Tissue factor pathway inhibitor-2 is a novel mitogen for vascular smooth muscle cells. Journal of Biological Chemistry, 274(9), 5379–5384. https://doi.org/10.1074/jbc.274.9.5379

Article  PubMed  Google Scholar 

Tanaka, Y., Utsumi, J., Matsui, M., Sudo, T., Nakamura, N., Mutoh, M., et al. (2004). Purification, molecular cloning, and expression of a novel growth-promoting factor for retinal pigment epithelial cells, REF-1/TFPI-2. Investigative Ophthalmology & Visual Science, 45(1), 245–252. https://doi.org/10.1167/iovs.03-0230

Article  Google Scholar 

Xu, Z., Maiti, D., Kisiel, W., & Duh, E. J. (2006). Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 26(12), 2819–2825. https://doi.org/10.1161/01.ATV.0000248731.55781.87

Article  PubMed  Google Scholar 

Yanamandra, N., Kondraganti, S., Gondi, C. S., Gujrati, M., Olivero, W. C., Dinh, D. H., et al. (2005). Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line. International Journal of Cancer, 115(6), 998–1005. https://doi.org/10.1002/ijc.20965

Article  PubMed  Google Scholar 

Sun, Y., Xie, M., Liu, M., Jin, D., & Li, P. (2006). Growth suppression of human laryngeal squamous cell carcinoma by adenovirus-mediated tissue factor pathway inhibitor gene 2. The Laryngoscope, 116(4), 596–601. https://doi.org/10.1097/01.mlg.0000205589.84020.d2

Article  PubMed  Google Scholar 

Zhu, B., Zhang, P., Zeng, P., Huang, Z., Dong, T. F., Gui, Y. K., et al. (2013). Tissue factor pathway inhibitor-2 silencing promotes hepatocellular carcinoma cell invasion in vitro. Anatomical Record (Hoboken), 296(11), 1708–1716. https://doi.org/10.1002/ar.22789

Article  Google Scholar 

Iino, M., Foster, D. C., & Kisiel, W. (1998). Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2. Arteriosclerosis, Thrombosis, and Vascular Biology, 18(1), 40–46. https://doi.org/10.1161/01.atv.18.1.40

Article  PubMed